BetterLife Pharma Inc. is a Health Care company. Its directors and officers file their transactions with SEDI. 7 insiders have disclosed 31 filings since 18 October 2025.
The flow runs one way only: 3 insiders bought (12 purchases totalling €52k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Sangha, Steven filed the largest purchase, €12k, on 27 May 2026. Among those who bought: 3 senior executives.
The latest purchase is recent: it was published 10 days ago, on 7 October 2026. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public.
For context, the typical company on the same exchange (median of 2,121 companies) published 11 filings over the same period, against 31 filings here. Our records for BetterLife Pharma Inc. go back to 2026, with 12 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended January 2026 · cache
25 of 31 declarations
BetterLife Pharma Inc. is a company focused on developing innovative therapeutic solutions in the healthcare and pharmaceutical sector. It is listed on the XTSE.